Perfusion Medical

Perfusion Medical is commercializing a breakthrough IV drug invented at VCU that dramatically improves survival in patients suffering from blood loss and shock.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Richmond, VA, USA
  • Currency USD
  • Founded March 2020
  • Employees 1
  • Incorporation Type C-corp
  • Website

Company Summary

Perfusion Medical is commercializing PEG-20k, a drug for the restoration of tissue perfusion developed by researchers at VCU with $12M in Army funding. PEG-20k is a promising potential therapy for patients affected by shock with potential annual sales of $4B and is referred to as a “game-changer” by independent doctors. In large animal trials, the patent-protected IV solution worked 10 to 20 times better than current standards of care.



Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free